Nila U. Parikh
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Gary E. GallickJustin M. SummySerk In ParkLee M. EllisAmi N. ShahJing ZhangCharles A. StaleyT. Christopher Windham
- Topics
- PI3K/AKT/mTOR signaling in cancer (10 papers)Liver physiology and pathology (6 papers)Colorectal Cancer Treatments and Studies (6 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Nila U. Parikh
39 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.5k
- Oncology 1.2k
- Cancer Research 522
- Pulmonary and Respiratory Medicine 314
- Pathology and Forensic Medicine 272
Countries citing papers authored by Nila U. Parikh
This map shows the geographic impact of Nila U. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nila U. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nila U. Parikh more than expected).
Fields of papers citing papers by Nila U. Parikh
This network shows the impact of papers produced by Nila U. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nila U. Parikh. The network helps show where Nila U. Parikh may publish in the future.
Co-authorship network of co-authors of Nila U. Parikh
This figure shows the co-authorship network connecting the top 25 collaborators of Nila U. Parikh. A scholar is included among the top collaborators of Nila U. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nila U. Parikh. Nila U. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 37 | |
| 3 | 36 | |
| 4 | 33 | |
| 5 | 15 | |
| 6 | 10 | |
| 7 | 100 | |
| 8 | 127 | |
| 9 | 36 | |
| 10 | Inhibition of colon tumor metastasis in orthotopic nude mouse models with the dual-selective Src/Abl kinase inhibitor, AZD0530 | 1 |
| 11 | 367 | |
| 12 | Combined activity of dasatinib (BMS-354825) and oxaliplatin in an orthotopic model of metastatic colorectal carcinoma | 4 |
| 13 | 99 | |
| 14 | 101 | |
| 15 | 129 | |
| 16 | 54 | |
| 17 | 144 | |
| 18 | 173 | |
| 19 | 40 | |
| 20 | 170 |
About Nila U. Parikh
Nila U. Parikh is a scholar working on Oncology, Hepatology and Hematology, having authored 39 papers that have together received 2.5k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (10 papers), Liver physiology and pathology (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (522 citations) and Immunology and Allergy (163 citations). Nila U. Parikh has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Gary E. Gallick, Justin M. Summy, Serk In Park, Lee M. Ellis, Ami N. Shah, Jing Zhang, Charles A. Staley, T. Christopher Windham, Donald P. Lesslie and Corazon D. Bucana. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.